• Hospitalized COPD Patients with AFib More Likely to Develop Complications, Study Reports
  • Verona Launches Phase 2 Trial Testing Investigational RPL554 Added to Stiolto Respimat
  • Inhaled Vaporized Cannabis Failed to Improve COPD Symptoms in Small Clinical Trial
  • FDA Advisory Committee Does Not Support Approval of GSK’s Mepolizumab for COPD
  • COPD Treatment with Targeted Lung Denervation Found Safe and Feasible, Study Reports
  • Low, Moderate Psychological Distress Increases Risk of COPD, Other Diseases, Study Shows
  • Social Support, Regular Exercise Can Help COPD Patients Remain Active, Review Study Says
  • FDA Approves Zephyr Valve for Patients with Severe Emphysema
  • New UK Study Recruiting Participants for Evaluation of Early COPD Risk Factors
  • Synairgen’s Antiviral Therapy SNG001 Proven Safe for COPD Patients in Phase 2 Trial
  • Corticosteroid Use Linked to Worse Health Outcomes in COPD Patients, Mouse Study Finds
  • PUR0200 Shown to Be as Good as Spiriva HandiHaler for COPD in Phase 1 Trial